November 5, 2026

A study investigates the effects of GLP-1 and GIP receptor agonism on human myotubes, finding no direct influence on muscle atrophy or myogenesis, suggesting indirect mechanisms behind lean mass loss.

This study evaluates the efficacy of retatrutide, a triple hormone receptor agonist, in treating obesity through a randomized controlled trial involving adults without diabetes.